Sun Pharmaceutical

Organon
Apr 27, 2026

Sun Pharma to acquire Merck spinoff Organon for $11.75B

The addition by India’s largest pharmaceutical company of the women's health-focused Merck spinoff will expand the buyer's global pharma footprint in that space and specialty medicines.

Richard Ascroft has been appointed CEO of Sun Pharma North America.
Jun 27, 2025

Sun Pharma names Ascroft North America CEO

Richard Ascroft is responsible for advancing the Princeton-based company’s portfolio of medicines, generics and over-the-counter products in the U.S. and Canada.

Researcher
Mar 13, 2025

Sun Pharma expanding Princeton HQ with $5.2M in tax credits

The world's fourth-largest specialty generic pharmaceutical company's new Princeton location will create 220 jobs and keep “hundreds" of positions in-state.